Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications

Pharmacotherapy to Prevent Alcohol Relapse in Alcohol-Associated Liver Disease.

Pharmacotherapy to Prevent Alcohol Relapse in Alcohol-Associated Liver Disease.

Journal: Current gastroenterology reports
Published: September 22, 2025

Integrating hepatology with addiction care for inpatients with alcohol use disorder reduces future liver-related events.

Integrating hepatology with addiction care for inpatients with alcohol use disorder reduces future liver-related events.

Journal: Hepatology communications
Published: March 16, 2025

Defining Risk in Alcohol-Associated Liver Disease Using the Model for End-Stage Liver Disease.

Defining Risk in Alcohol-Associated Liver Disease Using the Model for End-Stage Liver Disease.

Journal: The American journal of gastroenterology
Published: January 14, 2025

Defining risk in Alcohol associated Liver Disease using the Model for End Stage Liver Disease.

Defining risk in Alcohol associated Liver Disease using the Model for End Stage Liver Disease.

Journal: The American journal of gastroenterology
Published: January 14, 2025

Gastrointestinal and Liver Adverse Effects of Alcohol Use Disorder Medications: A Pharmacovigilance Analysis.

Gastrointestinal and Liver Adverse Effects of Alcohol Use Disorder Medications: A Pharmacovigilance Analysis.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: September 25, 2024

Prevalence and Clinical Correlation of Cardiometabolic Risk Factors in Alcohol-Related Liver Disease and Metabolic Dysfunction and Alcohol Associated Liver Disease (MetALD).

Prevalence and Clinical Correlation of Cardiometabolic Risk Factors in Alcohol-Related Liver Disease and Metabolic Dysfunction and Alcohol Associated Liver Disease (MetALD).

Journal: Journal of clinical and experimental hepatology
Published: September 10, 2024

Medications for Weight Loss and MASLD: A National Survey of Hepatology and Gastroenterology Provider Practices, Attitudes, and Knowledge Before Resmetirom.

Medications for Weight Loss and MASLD: A National Survey of Hepatology and Gastroenterology Provider Practices, Attitudes, and Knowledge Before Resmetirom.

Journal: Journal of clinical gastroenterology
Published: July 17, 2024

Reply: Is nesting addiction medicine and hepatology care in the outpatient setting worthwhile? A retrospective case series at a single tertiary center.

Reply: Is nesting addiction medicine and hepatology care in the outpatient setting worthwhile? A retrospective case series at a single tertiary center.

Journal: Hepatology communications
Published: June 20, 2024

Stigmatizing Language for Alcohol Use Disorder and Liver Disease on Liver Transplant Center Websites.

Stigmatizing Language for Alcohol Use Disorder and Liver Disease on Liver Transplant Center Websites.

Journal: JAMA network open
Published: February 08, 2024

Time to Include Inflammatory Bowel Disease as a Notifiable Disease?

Time to Include Inflammatory Bowel Disease as a Notifiable Disease?

Journal: Gastroenterology
Published: November 01, 2023

Proteomics identifies complement protein signatures in patients with alcohol-associated hepatitis.

Proteomics identifies complement protein signatures in patients with alcohol-associated hepatitis.

Journal: JCI insight
Published: July 24, 2023

Serum Fibroblast Growth Factor-21 Discriminates Between Decompensated Alcohol-Associated Cirrhosis and Severe Alcohol-Associated Hepatitis.

Serum Fibroblast Growth Factor-21 Discriminates Between Decompensated Alcohol-Associated Cirrhosis and Severe Alcohol-Associated Hepatitis.

Journal: Clinical and translational gastroenterology
Published: December 19, 2022
Showing 1-12 of 62

Last Updated: 01/07/2026